Less Ads, More Data, More Tools Register for FREE

Wednesday broker round-up UPDATE

Wed, 28th May 2014 09:57

Accesso Technology Group: Numis initiates with a target price of 690p and a buy recommendation.Alternative Networks: Westhouse Securities upgrades from add to buy with a target price of 540p.Astra Zeneca: Deutsche Bank raises target price from 3800p to 3950p and keeps a hold recommendation.AVEVA Group: UBS cuts target price from 2550p to 2500p downgrading from buy to neutral.Britvic: Numis raises target price from 684p to 765p, while its hold recommendation remains unchanged.BT Group: Goldman Sachs increases target price from 520p to 610p and retains a strong buy recommendation.Cable & Wireless Communications: Jefferies takes target price from 48p to 61p and maintains hold recommendation.De La Rue: Investec ups target price from 890p to 915p and leaves its buy recommendation unaltered.easyJet: JP Morgan cuts target price from 1965p to 1909p and keeps its overweight rating.Faroe Petroleum: Canaccord Genuity moves target price from 185p to 195p and reiterates a buy recommendation.Halfords Group: N+1 Singer ups target price from 540p to 600p retaining its buy recommendation.Iomart Group: FinnCap lowers target price from 330p to 325p and maintains a buy recommendation.OPG Power Ventures: Jefferies initiates with a target price of 120p and a buy recommendation.Punch Taverns: Numis upgrades to hold with a target price of 10p.Rockhopper Exploration: Westhouse Securities moves target price from 290p to 300p and stays with its buy recommendation.Sage Group: Citi raises target price from 395p to 450p and stays with its buy recommendation.Seplat Petroleum Development Company: Citi initiates with a target price of 270p and a neutral rating.Synergy Health: Canaccord Genuity increases target price from 987p to 1047p, but still recommends selling.Talk Talk Telecom: Goldman Sachs raises target price from 2310p to 2550p and leaves its strong buy recommendation unchanged.Vodafone Group: Berenberg cuts target price from 265p to 214p downgrading to hold. Nomura reduces target price from 240p to 200p and reiterates its neutral rating. Goldman Sachs ups target price from 225p to 240p and keeps a neutral rating.

Related Shares

More News
30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

30 May 2024 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

29 May 2024 08:54

IN BRIEF: AstraZeneca drug lowers cholesterol in phase 1 trial

AstraZeneca PLC - Cambridge, England-based pharmaceuticals - Reports positive results in a phase 1 trial of cholesterol drug candidate AZD0780, an ora...

28 May 2024 07:02

AstraZeneca experimental lung cancer drug shows promising results

(Sharecast News) - AstraZeneca's experimental lung cancer drug showed improved overall survival rates in phase III trials, the pharmaceutical giant sa...

27 May 2024 07:49

IN BRIEF: Astra, Daiichi hail positive survival data for Dato-DXd

AstraZeneca PLC - Cambridge, UK-based pharmaceutical firm - Alongside Japan's Daiichi Sankyo Co Ltd, notes positive data for datopotamab deruxtecan in...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.